Generation of human monoclonal allergen-specific IgE and IgG antibodies from synthetic antibody libraries

Clinical Chemistry

Volumn 53, Issue 5, 2007, Pages 837-844

  Braren, Ingke ^a   Blank, Simon ^a   Seismann, Henning ^a   Deckers, Susanne ^a   Ollert, Markus ^b   Grunwald, Thomas ^a   Spillner, Edzard ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BEE VENOM; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4;

APPLE; ARTICLE; BACTERIOPHAGE; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MEDICAL RESEARCH; MILK; NONHUMAN; RECEPTOR BINDING;

ALLERGENS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BEE VENOMS; CATTLE; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN VARIABLE REGION; MALUS; MILK; PEPTIDE LIBRARY; PROTEIN SUBUNITS; RECEPTORS, IGE; RECOMBINANT PROTEINS;

APOIDEA; BOVINAE; MALUS X DOMESTICA; MAMMALIA;

EID: 34248359820     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.078360     Document Type: Article

References (40)

1. Ishizaka K, Ishizaka T, Hornbrook MM. Physicochemical properties of reaginic antibody. V. Correlation of reaginic activity with gamma-E-globulin antibody. J Immunol 1966;97:840-53.
2. Cooke RA, Bernhard JH, Hebald S, Stull A. Serological evidence of immunity with coexisting sensitization in a type of human allergy (hay fever), J Exp Med 1935;62:733-51.
3. Lichtenstein LM, Holtzmann NA, Burnett LS. A quantitative in vitro study of the chromatographic distribution and immunoglobulin characteristics of human blocking antibody. J Immunol 1968;101: 317-24.
4. Jarolim E, Poulsen LK, Stadler BM, Mosbech H, Oesterballe O, Kraft D, et al. A long-term follow-up study of hyposensitization with immunoblotting. J Allergy Clin Immunol 1990;85:996-1004.
5. Daeron M, Malbec O, Latour S, Arock M, Fridman WH. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J Clin Invest 1995;95:577-85.
6. Malbec O, Attal JP, Fridman WH, Daeron M. Negative regulation of mast cell proliferation by FcgammaRIIB. Mol Immunol 2002;38: 1295-9.
7. Van Neerven RJ, Wikborg T, Lund G, Jacobsen B, Brinch-Nielsen A, Arnved J, et al. Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation. J Immunol 1999;163: 2944-52.
8. Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985; 228:1315-7.
9. McCafferty J, Griffiths AD, Winter G, Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 1990;348:552-4.
10. Griffiths AD, Williams SC, Hartley O, Tomlinson IM, Waterhouse P, Crosby WL, et al. Isolation of high affinity human antibodies directly from large synthetic repertoires. Embo J 1994;13:3245-60.
11. Clackson T, Hoogenboom HR, Griffiths AD, Winter G. Making antibody fragments using phage display libraries. Nature 1991; 352:624-8.
12. Burton DR, Barbas CF III, Persson MA, Koenig S, Chanock RM, Lerner, RA. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci U S A 1991;88:10134-7.
13. Barbas CF, III, Kang AS, Lerner RA, Benkovic SJ. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci U S A 1991;88:7978-82.
14. Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol 1991;222:581-97.
15. Barbas CF III, Bain JD, Hoekstra DM, Lerner RA. Semisynthetic combinatorial antibody libraries: a chemical solution to the diversity problem. Proc Natl Acad Sci U S A 1992;89:4457-61.
16. Hu Z, Sun Y, Garen A. Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model. Proc Natl Acad Sci U S A 1999;96: 8161-6.
17. Terskikh AV, Le Doussal JM, Crameri R, Fisch I, Mach JP, Kajava AV. "Peptabody": a new type of high avidity binding protein. Proc Natl Acad Sci U S A 1997;94:1663-8.
18. Choi I, De Ines C, Kurschner T, Cochlovius B, Sorensen V, Olafsen T, et al. Recombinant chimeric 0KT3 scFv IgM antibodies mediate immune suppression while reducing T cell activation in vitro. Eur J Immunol 2001;31:94-106.
19. Powers DB, Amersdorfer P, Poul M, Nielsen UB, Shalaby MR, Adams GP, et al. Expression of single-chain Fv-Fc fusions in Pichia pastoris. J Immunol Methods 2001;251:123-35.
20. Huls GA, Heijnen IA, Cuomo ME, Koningsberger JC, Wiegman L, Boel E, et al. A recombinant, fully human monoclonal antibody with antitumor activity constructed from phage-displayed antibody fragments. Nat Biotechnol 1999;17:276-81.
21. Persic L, Roberts A, Wilton J, Cattaneo A, Bradbury A, Hoogenboom HR. An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries. Gene 1997;187:9-18.
22. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977;36:59-74.
23. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, et al.. Current Protocols in Molecular Biology Greene Publishing Associates and Wiley-Interscience, New York, 1994.
24. Jarolim E, Rumpold H, Endler AT, Ebner H, Breitenbach M, Scheiner O, et al. IgE and IgG antibodies of patients with allergy to birch pollen as tools to define the allergen profile of Betula verrucosa. Allergy 1989;44:385-95.
25. Kemeny DM, Urbanek R, Ewan P, McHugh S, Richards D, Patel S, et al. The subclass of IgG antibody in allergic disease II. The IgG subclass of antibodies produced following natural exposure to dust mite and grass pollen in atopic and non-atopic individuals. Clin Exp Allergy 1989;19:545-9.
26. Svenson M, Jacobi HH, Bodtger U, Poulsen LK, Rieneck K, Bendtzen K. Vaccination for birch pollen allergy: induction of affinity-matured or blocking IgG antibodies does not account for the reduced binding of IgE to Bet v 1. Mol Immunol 2003;39:60 3-12.
27. Aalberse RC. Specific IgE and IgG responses in atopic versus nonatopic subjects. Am J Respir Crit Care Med 2000;162:124-7.
28. Hantusch B, Scholl I, Harwanegg C, Krieger S, Becker WM, Spitzauer S, et al. Affinity determinations of purified IgE and IgG antibodies against the major pollen allergens Phl p 5a and Bet v 1a: discrepancy between IgE and IgG binding strength. Immunol Lett 2005;97:81-9.
29. Zurcher AW, Lang AB, Aebischer I, Miescher S, Stadler BM. IgE-producing hybridomas established after B-cell culture in the CD40 system. Immunol Lett 1995;46:49-57.
30. Finlay WJ, deVore NC, Dobrovolskaia EN, Gam A, Goodyear CS, Slater JE. Exploiting the avian immunoglobulin system to simplify the generation of recombinant antibodies to allergenic proteins. Clin Exp Allergy 2005;35:1040-8.
31. Furtado PB, McElveen JE, Gough L, Armour KL, Clark MR, Sewell HF, et al. The production and characterisation of a chimaeric human IgE antibody, recognising the major mite allergen Der p 1, and its chimaeric human IgG1 anti-idiotype. Mol Pathol 2002;55: 315-24.
32. Steinberger P, Kraft D, Valenta R. Construction of a combinatorial IgE library from an allergic patient isolation and characterization of human IgE Fabs with specificity for the major timothy grass pollen allergen, phl p 5. J Biol Chem 1996;271:10967-72.
33. Laukkanen ML, Mäkinen-Kiljunen S, Isoherranen K, Haahtela T, Söderlund H, Takkinen K. Hevein-specific recombinant IgE antibodies from human single-chain antibody phage display libraries. J Immunol Methods 2003;278:271-81.
34. Müller U, Fricker M, Wymann D, Blaser K, Crameri R. Increased specificity of diagnostic tests with recombinant major bee venom allergen phospholipase A2. Clin Exp Allergy 1997;27:915-20.
35. Fromberg J. IgE as a marker in allergy and the role of IgE affinity. Allergy 2006;61:1234.
36. Jakobsen CG, Bodtger U, Kristensen P, Poulsen LK, Roggen EL. Isolation of high-affinity human IgE and IgG antibodies recognising Bet v 1 and Humicola lanuginosa lipase from combinatorial phage libraries. Mol Immunol 2004;41:941-53.
37. Jakobsen CG, Bodtger U, Poulsen LK, Roggen EL. Vaccination for birch pollen allergy: comparison of the affinities of specific immunoglobulins E, G1 and G4 measured by surface plasmon resonance. Clin Exp Allergy 2005;35:193-8.
38. Zhu D, Kepley CL, Zhang M, Zhang K, Saxon A. A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation. Nat Med 2002;8: 518-21.
39. Flicker S, Steinberger P, Norderhaug L, Sperr WR, Majlesi Y, Valent P, et al. Conversion of grass pollen allergen-specific human IgE into a protective IgG(1) antibody. Eur J Immunol 2002;32: 2156-62.
40. Kabat EA, Wu TT, Perry HM Gottesman KS, Foeller C. 1991 Sequences of Proteins of Immunological Interest, 5th ed, US Department of Health and Human Services, Bethesda, MD.